Acute Lymphoblastic Leukemia in Adolescents and Young Adults

49Citations
Citations of this article
50Readers
Mendeley users who have this article in their library.

Abstract

Today, long-term survival is achieved in more than 80% of children 1 to 10 years old with acute lymphoblastic leukemia (ALL). However, cure rates for adults and adolescents and young adults (AYA) with ALL remain relatively low, at only 40% to 50%. Age is a continuous prognostic variable in ALL, with no single age at which prognosis deteriorates markedly. Within childhood ALL populations, older children have shown inferior outcomes, whereas younger adults have shown superior outcomes among adult ALL patients. The type of treatment (pediatric-based versus adult-based) for AYA has recently been a matter of debate. In this article the biology and treatment of ALL in AYA is reviewed. © 2009 Elsevier Inc. All rights reserved.

Cite

CITATION STYLE

APA

Ribera, J. M., & Oriol, A. (2009, October). Acute Lymphoblastic Leukemia in Adolescents and Young Adults. Hematology/Oncology Clinics of North America. https://doi.org/10.1016/j.hoc.2009.07.002

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free